European Perspectives

UBC experts provided key insights at ISPOR 16th Annual European Congress
UBC - November 15, 2013
ISPOR 16th Annual European Congress, held November 2-6 in Dublin, was a great success, providing the opportunity for thought-provoking presentations as well as valuable networking and information sharing. Industry thought leaders...
Read UBC's article on Pharmacovigilance and Risk Management in the EU
UBC - October 23, 2013
The new EU pharmacovigilance legislation (Good Vigilance Practice, GVP) is now in effect and applicants need to be fully compliant.  Read UBC's latest article online now at    
UBC designs and manages observational studies that can help maximize a product's ROI
UBC - October 07, 2013
Traditional randomized controlled trials can help establish the efficacy and safety of pharmaceutical and biological products.  Yet manufacturer sponsors are facing increasing pressure to prove the value of a product.  That’...
UBC is a leader in creating customized risk minimization strategies
UBC - July 16, 2013
Pharmaceutical manufacturers understand that systems supporting approval and marketing for their products must be designed and implemented with a global outlook.   That’s easier said than done, taking into account the...
Annette Stemhagen, DrPH, FISPE, Senior Vice President, Safety, Epidemiology, Registries, & Risk Management - February 12, 2013
Manufacturers of pharmaceutical or biotech products or medical devices understand that the regulatory approval of their product is not the final hurdle.  Instead, it’s the beginning of a new set of challenges, requiring strategic...